nach oben

Drugs

Erschienen in:

01.12.2003 | Therapy in Practice

Excessive Daytime Sleepiness and Sleep Disturbances in Patients with Neurological Diseases

Epidemiology and Management

verfasst von: Dr Svenja Happe

Erschienen in: Drugs | Ausgabe 24/2003

Einloggen, um Zugang zu erhalten

Abstract

Up to 12% of the general population experience excessive daytime sleepiness (EDS), with increasing prevalence in the elderly. EDS may lead to cognitive impairment, resulting in inattentiveness, poor memory, mood disorders and an increased risk of accidents. As a result, quality of life is reduced in most patients with EDS as well as in their caregiving spouses. There are a variety of causes leading to EDS, including CNS pathology, neurological dysfunction, associated sleep disorders with insufficient or fragmented sleep, and drug therapy. Since EDS accompanies many neurological disorders, such as neurodegenerative and neuromuscular diseases, neurologists should be familiar with the diagnosis, its major causes and with treatment options.

The main focus of this article is on movement disorders, neuromuscular diseases, multiple sclerosis, dementia, cerebrovascular diseases, head and brain trauma, pain and epilepsy. General managment strategies for EDS in all these neurological diseases include sleep hygiene aspects such as extensions of noctural time in bed and frequent naps during the day. Pharmacological treatment is generally achieved with stimulants such as amphetamine, methylphenidate and pemoline, or newer compounds such as modafinil.

Connor J, Whitlock G, Norton R, et al. The role of driver sleepiness in car crashes: a systematic review of epidemiological studies. Accid Anal Prev 2001; 33: 31–41PubMed

Asplund R. Daytime sleepiness and napping amongst the elderly in relation to somatic health and medical treatment. J Intern Med 1996; 239: 261–7PubMed

American Sleep Disorders Association. International classification of sleep disorders, revised: diagnostic and coding manual. Rochester (NY): American Sleep Disorders Association, 1997

Mahowald MW. Eyes wide shut: the dangers of sleepy driving. Minn Med 2000; 83: 25–30PubMed

El-Ad B, Korczyn AD. Disorders of excessive daytime sleepiness: an update. J Neurol Sci 1998; 153: 192–202PubMed

Guilleminault C, Brooks SN. Excessive daytime sleepiness: a challenge for the practising neurologist. Brain 2001; 124: 1482–91PubMed

Roth T, Roehrs TA. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther 1996; 18: 562–76PubMed

Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991; 36: 291–8PubMed

Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540–5PubMed

10.

Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431–6PubMed

11.

Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997; 20: 835–43PubMed

12.

Richardson GS, Carskadon MA, Flagg W, et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978; 45: 621–7PubMed

13.

Mitler MM, Krishnareddy SG, Browman CP. Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electroencephalogr Clin Neurophysiol 1982; 53: 658–61PubMed

14.

Bennett LS, Stradling JR, Davies RJ. A behavioural test to assess daytime sleepiness in obstructive sleep apnea. J Sleep Res 1997; 16: 142–5

15.

Wilhelm B, Wilhelm H, Lüdtke H, et al. Pupillographic assessment of sleepiness in sleep-deprived healthy subjects. Sleep 1998; 21: 258–65PubMed

16.

Meier-Ewert K. Abnorme Tagesschläfrigkeit: Ansätze zu einer Typologie. Ther Umsch 1991; 48: 746–50PubMed

17.

Mackworth NH. Vigilance. Advancement Sci 1957; 53: 389–93

18.

Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 2000; 9: 5–11PubMed

19.

Happe S, Pirker W, Sauter C, et al. Successful treatment of excessive daytime sleepiness in Parkinson’s disease with modafinil. J Neurol 2001; 248: 632–4PubMed

20.

Nieves AV, Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil. Clin Neuropharmacol 2002; 25: 111–4PubMed

21.

Damian MS, Gerlach A, Schmidt F, et al. Modafmil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001; 56: 794–6PubMed

22.

Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72(2): 179–83PubMed

23.

Parkes JD, Tarsy D, Marsden CD, et al. Amphetamines in the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry 1975; 38: 232–7PubMed

24.

Van der Meche FG, Bogaard JM, van der Sluys JC, et al. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry 1994; 57: 626–8PubMed

25.

Miyamoto T, Miyamoto M, Suga T, et al. Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy. Psychiatry Clin Neurosci 2002; 56: 271–2PubMed

26.

Happe S, Trenkwalder C. Movement disorders in sleep: Parkinson’s disease and restless legs syndrome. Biomed Tech (Berl) 2003 Mar; 48(3): 62–7

27.

Chokroverty S. Sleep and degenerative neurologic disorders. Neurol Clin 1996; 4: 807–26

28.

Fish DR, Sawyers D, Allen PJ, et al. The effect of sleep on the dyskinetic movements of Parkinson’s disease, Gilles de la Tourette syndrome, Huntington’s disease, and torsion dystonia. Arch Neurol 1991; 48: 210–4PubMed

29.

Rothenberger A, Kostanecka T, Kinkelbur J, et al. Sleep and Tourette syndrome. In: Cohen DJ, Goetz CG, Jankovic J, editors. Tourette syndrome. Philadelphia (PA): Lippincott Williams and Wilkins, 2001: 245–59

30.

Boeve BF, Silber MH, Ferman TJ, et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16: 622–30PubMed

31.

Eisensehr I, Lindeiner H, Jäger M, et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography? J Neurol Sci 2001; 186:7–11PubMed

32.

Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community based study. Mov Disord 1999; 14: 922–7PubMed

33.

Factor SA, McAlarney T, Sanchez-Ramoz JR, et al. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990; 5: 280–5PubMed

34.

Tan EK, Lum SY, Fook-Chong SM, et al. Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controls. Neurology 2002; 58: 465–8PubMed

35.

O’Suilleabhain PE, Dewey Jr RB. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002; 59: 986–9PubMed

36.

Frucht S, Rogers J, Greene P, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908–10PubMed

37.

Ryan M, Slevin JD, Wells A. Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy 2000; 20: 724–6PubMed

38.

Pal S, Bhattacharya KF, Agapito C, et al. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001; 108:71–7PubMed

39.

Happe S, Berger K. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson’s disease: a prospective study. J Neurol 2001; 248: 1062–7PubMed

40.

Chaudhuri KR, Pal S, Bridgman K, et al. Achieving 24-hour control of Parkinson’s disease symptoms: use of objective measures to improve nocturnal disability. Eur Neurol 2001; 46 Suppl. 1: 3–10PubMed

41.

Happe S, Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson’s disease. Age Ageing 2002; 31: 349–54PubMed

42.

Karlsen KH, Larsen JP, Tandberg E, et al. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999; 66: 431–5PubMed

43.

Schenck C, Hurwitz T, Mahowald M. REM sleep behavior disorder: an update on a series of 96 patients and a review of the world literature. J Sleep Res 1993; 2: 224–31PubMed

44.

Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331–9PubMed

45.

Voderholzer U, Müller N, Haag C, et al. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette’s syndrome. J Neurol 1997; 244: 521–6PubMed

46.

Tarajanovic NN, Shapiro CM, Sandor P. REM sleep behaviour disorder in patients with Tourette’s syndrome [abstract]. Sleep Res 1997; 26: 524

47.

Cohrs S, Rasch T, Altmeyer S, et al. Decreased sleep quality and increased sleep related movements in patients with Tourette’s syndrome. J Neurol Neurosurg Psychiatry 2001; 70: 192–7PubMed

48.

Glaze DG, Frost Jr JD, Jankovic J. Sleep in Gilles de la Tourette’s syndrome: disorder of arousal. Neurology 1983; 33: 586–92PubMed

49.

Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette’s syndrome. Can J Neurol Sci 1987; 14: 541–6PubMed

50.

Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette’s disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997; 154: 1277–84PubMed

51.

Butler IJ, Doslow SH, Sieger WE, et al. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 1979; 6: 37–9PubMed

52.

Mendelson WB, Caine ED, Goyer P, et al. Sleep in Gilles de la Tourette syndrome. Biol Psychiatry 1980; 15: 339–43PubMed

53.

Bollen EL, den Heijer JC, Ponsioen C, et al. Respiration during sleep in Huntington’s chorea. J Neurol Sci 1988; 84: 63–8PubMed

54.

Hansotia P, Wall R, Berendes J. Sleep disturbances and severity of Huntington’s disease. Neurology 1985; 34: 1672–4

55.

Wiegand M, Möller AA, Lauer CJ, et al. Nocturnal sleep in Huntington’s disease. J Neurol 1991; 238: 203–8PubMed

56.

Feigin A, Kiebertz K, Shoulson I. Treatment of Huntington’s disease and other choreic disorders. In: Kurlan R, editor. Treatment of movement disorders. Philadelphia (PA): JB Lippincott, 1994: 337–64

57.

Fish DR, Allen PJ, Sawyers D. Sleep spindles in torsion dystonia. Arch Neurol 1990; 47: 216–8PubMed

58.

Fish DR, Sawyers D, Smith SJ, et al. Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep. J Neurol Neurosurg Psychiatry 1991; 54: 140–4PubMed

59.

Jankel WR, Niedermeyer E, Graf M, et al. Polysomnography of torsion dystonia. Arch Neurol 1984; 41: 1081–3PubMed

60.

Bressman SB. Dystonia update. Clin Neuropharmacol 2000; 23: 239–51PubMed

61.

Montplaisir J, Boucher S, Poirier G, et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12: 61–5PubMed

62.

Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17: 739–43PubMed

63.

Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160: 2137–41PubMed

64.

Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO Study. Neurology 2000; 54: 1064–8PubMed

65.

Ancoli-Israel S, Kripke DM, Klauber MR, et al. Periodic limb movements in sleep in community dwelling elderly. Sleep 1991; 14: 496–500PubMed

66.

Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the ‘night walkers’ survey. Neurology 1996; 46: 92–5PubMed

67.

Hening W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 970–99PubMed

68.

Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54: 1698–700PubMed

69.

Banno K, Delaive K, Walld R, et al. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 2000; 1: 221–9PubMed

70.

Machtey I, Tiqwa P. Restless legs syndrome: a metabolic disorder [letter]? Arch Intern Meds 1996; 156: 2386PubMed

71.

Ondo W, Tan EK, Mansoor J. Rheumatologic serologies in secondary restless legs syndrome. Mov Disord 2000; 15: 321–3PubMed

72.

Lugaresi E, Coccagna G, Tassinari CA, et al. Polygraphic data on motor phenomena in the restless legs syndrome. Riv Neurol 1965; 35: 550–61PubMed

73.

Atlas Task Force of the American Sleep Disorders Association. Recording and scoring of leg movements. Sleep 1993; 16: 748–59

74.

Montplaisir J, Nicolas A, Godbout R, et al. Restless legs syndrome and periodic limb movement disorder. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia (PA): WB Saunders, 2000: 742–52

75.

Kazenwadel J, Pollmacher T, Trenkwalder C, et al. New actigraphic assessment method for periodic leg movements (PLM). Sleep 1995; 18: 689–97PubMed

76.

Michaud M, Lavigne G, Desautels A, et al. Effects of immobility on sensory and motor symptoms of restless legs syndrome. Mov Disord 2002; 17: 112–5PubMed

77.

Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 2003; 4(2): 101–19

78.

Hornyak M, Kotterba S, Trenkwalder C. Indications for performing polysomnography in the diagnosis and treatment of restless legs syndrome. Somnologie 2001; 5: 159–62

79.

Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 1993; 16: 713–6PubMed

80.

Chesson AL, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine Report. Standards of Practice Committee of the Academy of Sleep Medicine. Sleep 1999; 22: 961–8

81.

Walters AS. Toward a better definition of restless legs syndrome: the International Restless Legs Syndrome Study Group. Mov Disord 1995; 10: 634–42PubMed

82.

Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry 1999; 60: 241–4PubMed

83.

Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16: 327–32PubMed

84.

Walters AS, Winkelmann J, Trenkwalder C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16: 1105–9PubMed

85.

Montagna P, Sassoli de Bianchi L, Zucconi M, et al. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984; 69: 428–30PubMed

86.

Telstad W, Sorensen O, Larsen S, et al. Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ 1984; 288: 444–6PubMed

87.

Happe S, Klösch G, Saletu B, et al. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001; 57: 1717–9PubMed

88.

Garcia-Borruguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002; 59: 1573–9

89.

Guilleminault C, Stoohs R, Quera-Salva MA. Sleep-related obstructive and nonobstructive apneas and neurologic disorders. Neurology 1992; 42 (6 Suppl.): 53–60PubMed

90.

George CF. Neuromuscular disorders. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia (PA): WB Saunders Company, 1994: 776–81

91.

Barthlen GM. Nocturnal respiratory failure as an indication of non-invasive ventilation in the patient with neuromuscular disease. Respiration 1997; 64 (1 Suppl.): 35–8PubMed

92.

Culebras A. Sleep and neuromuscular disorders. Neurol Clin 1996; 1: 791–805

93.

Amino A, Shiozawa Z, Nagasaka T, et al. Sleep apnoea in well-controlled myasthenia gravis and the effect of thymectomy. J Neurol 1998; 245: 77–80PubMed

94.

Kryger MH. Restrictive lung diseases. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia (PA): WB Saunders Company, 1994: 769–75

95.

Giubilei F, Antonini G, Bastianello S, et al. Excessive daytime sleepiness in myotonic dystrophy. J Neurol Sci 1999; 164: 60–3PubMed

96.

Van Hilten JJ, Weggeman M, van der Velde EA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm 1993; 5: 235–44

97.

Barthlen GM, Lange DJ. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis. Eur J Neurol 2000; 7: 299–302PubMed

98.

Quera-Salva MA, Guilleminault C, Chevret S, et al. Breathing disorders during sleep in myasthenia gravis. Ann Neurol 1992; 31: 86–92PubMed

99.

Stepansky R, Weber G, Zeitlhofer J. Sleep apnea and cognitive dysfunction in myasthenia gravis. Acta Med Austriaca 1997; 24: 128–31PubMed

100.

Steljes DG, Kryger MH, Kirk BW, et al. Sleep in postpolio syndrome. Chest 1990; 98(1): 133–40PubMed

101.

Filippi M, Rocca MA, Colombo B, et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15: 559–67PubMed

102.

Rossini PM, Pasqualetti P, Pozzilli C, et al. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 2001;7: 354–8PubMed

103.

McGaffigan S, Bliwise DL. The treatment of sundowning: a selective review of pharmacological and nonpharmacological studies. Drugs Aging 1997; 10: 10–7PubMed

104.

Ancoli-Israel S, Klauber MR, Gillin JC, et al. Sleep in non-institutionalised Alzheimer’s patients. Aging (Milano) 1994; 6: 451–8

105.

Cardinali DP, Brusco LI, Liberczuk C, et al. The use of melatonin in Alzheimer’s disease. Neuroendocrinol Lett 2002; 23 Suppl. 1: 20–3PubMed

106.

Pollack CP, Stokes PE. Circadian rest-activity in demented and non-demented older community residents and their caregivers. J Am Geriatr Soc 1997; 45: 446–52

107.

Bader GG, Turesson K, Wallin A. Sleep related breathing and movement disorders in healthy elderly and demented subjects. Dementia 1996; 7: 279–87PubMed

108.

Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry 2000; 15: 1028–33PubMed

109.

Cibula JE, Eisenschenk S, Gold M, et al. Progressive dementia and hypersomnolence with dream-enacting behavior: oneiric dementia. Arch Neurol 2002; 59: 630–4PubMed

110.

Foley D, Monjan A, Masaki K, et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in Japanese-American men. J Am Geriatr Soc 2001; 49: 1628–32PubMed

111.

Shochat T, Loredo J, Ancoli-Israel S. Sleep disorders in the elderly. Curr Treat Options Neurol 2001; 3: 19–36PubMed

112.

Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia. Neurology 1998; 51: 363–70PubMed

113.

Ancoli-Israel S, Martin JL, Kripke DF, et al. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc 2002; 50: 282–9PubMed

114.

Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22: 217–23PubMed

115.

Bassetti Mathis J, Gugger M, et al. Hypersomnia following paramedian thalamic stroke. A report of 12 patients. Ann Neurol 1996; 39: 471–80

116.

Qureshi AI, Giles WH, Croft JB, et al. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology 1997; 48: 904–11PubMed

117.

Masel BE, Scheibel RS, Kimbark T, et al. Excessive daytime sleepiness in adults with brain injuries. Arch Phys Med Rehabil 2001;82: 1526–32PubMed

118.

Guilleminault C, Yuen KM, Gulevich MG, et al. Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology 2000; 54: 653–9PubMed

119.

Guilleminault C, Faull KF, Miles L, et al. Posttraumatic excessive daytime sleepiness: a review of 20 patients. Neurology 1983; 33: 1584–9PubMed

120.

Happe S, Zeitlhofer J, Evers S. Schlafgebundene Kopfschmerzen. Wien Klin Wochenschr 2001; 113: 259–65PubMed

121.

Beghi E. Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1996; 27: 323–30

122.

Manni R, Tartara A. Evaluation of sleepiness in epilepsy. Clin Neurophysiol 2000; 111 (2 Suppl.): 111–4

123.

Malow BA, Bowes RJ, Lin X. Predictors of sleepiness in epilepsy patients. Sleep 1997; 20: 1105–10PubMed

124.

Vaughan BV, D’Cruz OF, Beech R, et al. Prevalence of sleep complaints in patients with epilepsy: application of the Epworth sleepiness scale [abstract]. J Sleep Res 1997; 25: 453

125.

Manni R, Politini L, Sartori I, et al. Daytime sleepiness in epilepsy patients: evaluation by means of the Epworth sleepiness scale. J Neurol 2000; 247: 716–7PubMed

126.

Foldvary N. Sleep and epilepsy. Curr Treat Options Neurol 2002; 4: 129–35PubMed

127.

Mitler MM, Erman M, Hajdukovic R. The treatment of excessive somnolence with stimulant drugs. Sleep 1993; 16: 203–6PubMed

Titel: Excessive Daytime Sleepiness and Sleep Disturbances in Patients with Neurological Diseases
Epidemiology and Management
verfasst von: Dr Svenja Happe
Publikationsdatum: 01.12.2003
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe 24/2003
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200363240-00003

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excessive Daytime Sleepiness and Sleep Disturbances in Patients with Neurological Diseases

Epidemiology and Management

Abstract

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 24/2003

What is the Role of NSAIDs in Pre-emptive Analgesia?

Enfuvirtide

Enfuvirtide

Clinical Pharmacology of Proton Pump Inhibitors

Basiliximab

Acknowledgement